Shares of Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seventeen research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and ten have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $570.0625.
SNPS has been the topic of several recent analyst reports. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Bank of America boosted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. BNP Paribas Exane boosted their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Morgan Stanley boosted their price objective on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th.
Get Our Latest Stock Report on SNPS
Synopsys Trading Down 0.7%
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the firm posted $3.67 EPS. The company’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts forecast that Synopsys will post 10.65 EPS for the current fiscal year.
Synopsys News Summary
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Piper Sandler upgraded Synopsys to Overweight and lifted its price target, citing stronger IP business prospects and potential tailwinds from Intel foundry activity and Apple-related opportunities. Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Positive Sentiment: Commentary continues to highlight Synopsys as a strong AI-era semiconductor software name, with recurring revenue, expanding AI-driven design tools, and IP licensing viewed as competitive advantages. Synopsys vs. Applied Digital: Which AI Stock Has an Edge Right Now?
- Positive Sentiment: Several recent articles frame the stock’s pullback as potentially attractive, with some analysts/model-driven commentary suggesting meaningful upside from current levels. Synopsys Eyes 23% Upside Despite Recent Pullback
- Neutral Sentiment: Additional coverage focused on broader Wall Street research-call roundups and general analyst optimism for Synopsys, which reinforces sentiment but does not add a new company-specific catalyst. Here Are Tuesday’s Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More
Insider Activity
In other news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the company. Sankala Group LLC bought a new stake in shares of Synopsys during the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys during the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys during the 4th quarter worth about $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys during the 1st quarter worth about $30,000. Finally, Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys during the 4th quarter worth about $32,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
